{
  "input": {
    "mode": "execute_actions",
    "query": {
      "entity": "Atypical haemolytic uraemic syndrome",
      "relation": "indication"
    },
    "items": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_eculizumab",
            "via": [],
            "to": "disease_a_typical_haemolytic_uraemic_syndrome",
            "success_criteria": "确认无新增冲突且连通路径清晰",
            "assignee": "Proponent"
          },
          {
            "type": "add_mechanism_link",
            "from": "drug_ravulizumab",
            "via": [],
            "to": "disease_a_typical_haemolytic_uraemic_syndrome",
            "success_criteria": "确认无新增冲突且连通路径清晰",
            "assignee": "Proponent"
          }
        ]
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_caplacizumab",
          "type": "Drug",
          "label": "Caplacizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_anticoagulants",
          "type": "Drug",
          "label": "Anticoagulants",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_plasmapheresis",
          "type": "Drug",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_dialysis",
          "type": "Drug",
          "label": "Dialysis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_supportive_care",
          "type": "Drug",
          "label": "Supportive care",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_fibrinogen_concentrate",
          "type": "Drug",
          "label": "Fibrinogen concentrate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mycophenolate_mofetil",
          "type": "Drug",
          "label": "Mycophenolate mofetil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_a_typical_haemolytic_uraemic_syndrome",
          "type": "Disease",
          "label": "Atypical haemolytic uraemic syndrome",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Eculizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Caplacizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Anticoagulants",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Dialysis",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Supportive care",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Fibrinogen concentrate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Rituximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Mycophenolate mofetil",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_eculizumab",
          "target": "disease_a_typical_haemolytic_uraemic_syndrome",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "已知用于治疗该病症"
        },
        {
          "source": "drug_ravulizumab",
          "target": "disease_a_typical_haemolytic_uraemic_syndrome",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "可作为Eculizumab的替代药物"
        },
        {
          "source": "drug_corticosteroids",
          "target": "disease_a_typical_haemolytic_uraemic_syndrome",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "常用于减轻炎症反应"
        },
        {
          "source": "drug_caplacizumab",
          "target": "disease_a_typical_haemolytic_uraemic_syndrome",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "用于与血栓有关的病症"
        },
        {
          "source": "drug_anticoagulants",
          "target": "disease_a_typical_haemolytic_uraemic_syndrome",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "在某些情况减少凝血相关风险"
        },
        {
          "source": "drug_plasmapheresis",
          "target": "disease_a_typical_haemolytic_uraemic_syndrome",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "用于去除血液中的有害成分"
        },
        {
          "source": "drug_dialysis",
          "target": "disease_a_typical_haemolytic_uraemic_syndrome",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "用于肾功能不全的支持"
        },
        {
          "source": "drug_supportive_care",
          "target": "disease_a_typical_haemolytic_uraemic_syndrome",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "作为基础护理支持"
        },
        {
          "source": "drug_fibrinogen_concentrate",
          "target": "disease_a_typical_haemolytic_uraemic_syndrome",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "在凝血相关治疗中的应用"
        },
        {
          "source": "drug_rituximab",
          "target": "disease_a_typical_haemolytic_uraemic_syndrome",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "可能在免疫调节中发挥作用"
        },
        {
          "source": "drug_mycophenolate_mofetil",
          "target": "disease_a_typical_haemolytic_uraemic_syndrome",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "用于抑制免疫反应"
        },
        {
          "source": "drug_cyclosporine",
          "target": "disease_a_typical_haemolytic_uraemic_syndrome",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "免疫抑制用于各种自身免疫疾病"
        }
      ],
      "round_index": 3
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "hypothesis_id": "H1",
    "executed_actions": [
      {
        "action_ref": 0,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [],
          "merge": [],
          "set_weights": []
        },
        "notes": "已确认 Eculizumab 继续支持 Atypical haemolytic uraemic syndrome 相关路径"
      },
      {
        "action_ref": 1,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [],
          "merge": [],
          "set_weights": []
        },
        "notes": "已确认 Ravulizumab 继续支持 Atypical haemolytic uraemic syndrome 相关路径"
      }
    ],
    "unexecuted_actions": [],
    "residual_gaps": []
  }
}